REFERENCES
- Centers for Disease Control and Prevention. Available at: http://www.cdc.gov/hiv/topics/surveillance/resources/slides/pediatric/index.htm http://www.cdc.gov/hiv/topics/surveillance/resources/reports/2005report/table4.htm. Cases of HIV infection and AIDS in the United States and Dependent Areas, 2005 HIV/AIDS Surveillance Report, Volume 17, Revised Edition, June 2007. Accessed July 15th 2009.
- Malow RM, Ireland SJ. A description of the maternal addiction program of the University of Miami/Jackson Memorial Medical Center. J Substance Abuse Treat 1994; 11:55–60.
- Gossop M, Marsden J, Stewart D, Treacy S. Reduced injection risk and sexual risk behaviors after drug misuse treatment: Results from the National Treatment Outcome Research Study. AIDS Care 2002; 14:77–93.
- Elifson KW, Klein H. Predictors of sexual risk taking among new drug users. J Sex Research 2006; 43:318–327.
- Coady MH, Latka MH, Thied H, Colub ET, Ouellet L, Hudson SM, Kapadia F, Garfein RS. Housing status and associated differences in HIV risk behaviors among young injection drug users. AIDS Behavior 2007; 11:854–863.
- Simpson DD, Knight K, Ray S. Psychosocial correlates of AIDS-risk drug use and sexual behaviors. AIDS Ed Prevent 1993; 5:121–130.
- Centers for Disease Control and Prevention. Drug associated HIV transmission continues in the United States. 2002. Available at: http://www.cdc.gov/hiv/resources/Factsheets/idu.htm. Accessed July 15th 2009.
- McLellan AT, Luborsky L, Woody GE, O’Brien CP. An improved diagnostic evaluation instrument for substance abuse patients. The Addiction Severity Index. J Nerv Mental Dis 1980; 168:26–33.
- McLellan AT, Alterman AI, Cacciola J, Metzger D, O’Brien CP. A new measure of substance abuse treatment. Initial studies of the treatment services review. J Nerv Mental Dis 1992; 180:101–110.
- Kissin WB, Svikis DS, Moylan P, Huag NA, Stitzer ML. Identifying pregnant women at risk for early attrition from substance abuse treatment. J Substance Abuse Treat 2004; 27:31–38.
- Jones HE, O’Grady KE, Malfi D, Tuten M. Methadone maintenance vs. methadone taper during pregnancy; Maternal and neonatal outcomes. Am J Addictions 2008: 17:372–386.
- Brewer-Smyth K, Bucurescu G, Shults J, Metzger D, Sacktor N, van Gorp W, Kolson D. Neurological function and HIV risk behaviors of female prison inmates. J Neurosci Nurs 2007; 39:361–372.
- Jones HE, Wong CJ, Tuten M, Stitzer ML. Reinforcement-based therapy: 12-month evaluation of an outpatient drug-free treatment for heroin abusers. Drug Alcohol Depend 2005; 79:119–128.
- Jansson LM, Svikis DS, Velez M, Fitzgerald E, Jones HE. The impact of managed care on drug-dependent pregnant and postpartum women and their children. Subst Use Misuse 2007; 42:961–74.
- Metzger D, Woody GE, Navaline H, McLellan AT, Meyers K, Boney T, Mulvaney F, Williams J, Dyanick ST, Jonson A, Davis B, Green P, Abrams M, Oglesby P, Davis R, Zanis D, Abellanas L, Incmicoski R, O’Brien CP. The Risk Assessment Battery (RAB): Validity and Reliability. Paper presented at the Sixth Annual Meeting of National Cooperative Vaccine Development Group for AIDS 1993.
- Twitchell GR, Huber A, Reback CJ, Shoptaw S. Compariosn of general and detailed HIV risk assessment among methamphetamine abusers. AIDS Behav 2002; 6:153–162.
- Agosti V, Nunes E, Ocepeck-Welikson K. Patient factors related to early attrition from an outpatient cocaine research clinic. Am J Drug Alcohol Abuse 1996; 22:29–39.
- Sorenson JL, Copelan AL. Drug abuse treatment as an HIV prevention strategy: a review. Drug and Alcohol Dependence 2000; 59:17–31.
- Metzger DS, Navaline H. Human Immunodeficiency Virus prevention and the potential of drug abuse treatment. Clinical Infectious Diseases 2003; 37(Suppl 5):S451–456.